Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors

被引:161
作者
Kang, Xunlei [1 ]
Kim, Jaehyup [1 ]
Deng, Mi [1 ]
John, Samuel [1 ]
Chen, Heyu [1 ]
Wu, Guojin [1 ]
Phan, Hiep [1 ]
Zhang, Cheng Cheng [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA
关键词
cancer; CD85; HLA; ILT; immunoglobulin-like transcript; immunoreceptor tyrosine-based activation motif; Immunoreceptor tyrosine-based inhibitory motifs; ITAM; ITIM; leukemia; leukocyte immunoglobulin-like receptor subfamily B; leukocyte immunoglobulin-like receptor; LILRB; LIR; MHC; phosphatase; SHIP; SHP-1; SHP-2; signal transduction; MHC CLASS-I; ACUTE MYELOID-LEUKEMIA; MAST-CELL ACTIVATION; TYROSINE PHOSPHATASES SHP-1; ANTIGEN-PRESENTING CELLS; HUMAN DENDRITIC CELLS; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE; FC-GAMMA-RIIB; HLA-G;
D O I
10.1080/15384101.2015.1121324
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Inhibitory leukocyte immunoglobulin-like receptors (LILRBs 1-5) transduce signals via intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit protein tyrosine phosphatase non-receptor type 6 (PTPN6 or SHP-1), protein tyrosine phosphatase non-receptor type 11 (PTPN11 or SHP-2), or Src homology 2 domain-containing inositol phosphatase (SHIP), leading to negative regulation of immune cell activation. Certain of these receptors also play regulatory roles in neuronal activity and osteoclast development. The activation of LILRBs on immune cells by their ligands may contribute to immune evasion by tumors. Recent studies found that several members of LILRB family are expressed by tumor cells, notably hematopoietic cancer cells, and may directly regulate cancer development and relapse as well as the activity of cancer stem cells. LILRBs thus have dual concordant roles in tumor biology - as immune checkpoint molecules and as tumor-sustaining factors. Importantly, the study of knockout mice indicated that LILRBs do not affect hematopoiesis and normal development. Therefore LILRBs may represent ideal targets for tumor treatment. This review aims to summarize current knowledge on expression patterns, ligands, signaling, and functions of LILRB family members in the context of cancer development.
引用
收藏
页码:25 / 40
页数:16
相关论文
共 194 条
[11]   LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection [J].
Bashirova, Arman A. ;
Martin-Gayo, Enrique ;
Jones, Des C. ;
Qi, Ying ;
Apps, Richard ;
Gao, Xiaojiang ;
Burke, Patrick S. ;
Taylor, Craig J. ;
Rogich, Jerome ;
Wolinsky, Steven ;
Bream, Jay H. ;
Duggal, Priya ;
Hussain, Shehnaz ;
Martinson, Jeremy ;
Weintrob, Amy ;
Kirk, Gregory D. ;
Fellay, Jacques ;
Buchbinder, Susan P. ;
Goedert, James J. ;
Deeks, Steven G. ;
Pereyra, Florencia ;
Trowsdale, John ;
Lichterfeld, Mathias ;
Telenti, Amalio ;
Walker, Bruce D. ;
Allen, Rachel L. ;
Carrington, Mary ;
Yu, Xu G. .
PLOS GENETICS, 2014, 10 (03)
[12]   Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation [J].
Binstadt, BA ;
Brumbaugh, KM ;
Dick, CJ ;
Scharenberg, AM ;
Williams, BL ;
Colonna, M ;
Lanier, LL ;
Kinet, JP ;
Abraham, RT ;
Leibson, PJ .
IMMUNITY, 1996, 5 (06) :629-638
[13]   The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1 [J].
Bléry, M ;
Kubagawa, H ;
Chen, CC ;
Vély, F ;
Cooper, MD ;
Vivier, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2446-2451
[14]   Blocking PirB up-regulates spines and functional synapses to unlock visual cortical plasticity and facilitate recovery from amblyopia [J].
Bochner, David N. ;
Sapp, Richard W. ;
Adelson, Jaimie D. ;
Zhang, Siyu ;
Lee, Hanmi ;
Djurisic, Maja ;
Syken, Josh ;
Dan, Yang ;
Shatz, Carla J. .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (258) :258ra140
[15]  
Borges L, 1997, J IMMUNOL, V159, P5192
[16]   Inhibition of Th2 Adaptive Immune Responses and Pulmonary Inflammation by Leukocyte Ig-Like Receptor B4 on Dendritic Cells [J].
Breslow, Rebecca G. ;
Rao, Jayanti J. ;
Xing, Wei ;
Hong, David I. ;
Barrett, Nora A. ;
Katz, Howard R. .
JOURNAL OF IMMUNOLOGY, 2010, 184 (02) :1003-1013
[17]   The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection [J].
Brown, Damien P. ;
Jones, Des C. ;
Anderson, Katie J. ;
Lapaque, Nicolas ;
Buerki, Robin A. ;
Trowsdale, John ;
Allen, Rachel L. .
BMC IMMUNOLOGY, 2009, 10 :56
[18]   Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by FcγRIIB [J].
Bruhns, P ;
Vély, F ;
Malbec, O ;
Fridman, WH ;
Vivier, E ;
Daëron, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37357-37364
[19]   HLA-G: An Immune Checkpoint Molecule [J].
Carosella, Edgardo D. ;
Rouas-Freiss, Nathalie ;
Roux, Diana Tronik-Le ;
Moreau, Philippe ;
LeMaoult, Joel .
ADVANCES IN IMMUNOLOGY, VOL 127, 2015, 127 :33-144
[20]   gp49BI-αvβ3 interaction inhibits antigen-induced mast cell activation [J].
Castells, MC ;
Klickstein, LB ;
Hassani, K ;
Cumplido, JA ;
Lacouture, ME ;
Austen, KF ;
Katz, HR .
NATURE IMMUNOLOGY, 2001, 2 (05) :436-442